Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 7, 2013, Pages 989-1001

  Crupi, Rosalia ^a   Paterniti, Irene ^a   Ahmad, Akbar ^a   Campolo, Michela ^a   Esposito, Emanuela ^a   Cuzzocrea, Salvatore ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Antidepressant; Behavior; Depression; Inflammation; Mice; Neurogenesis

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; LUTEOLIN; PALMIDROL; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; DENSITOMETRY; DEPRESSION; DIFFERENTIAL SCANNING CALORIMETRY; FOOD INTAKE; FORCED SWIMMING TEST; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; MOUSE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OPEN FIELD TEST; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; WESTERN BLOTTING; X RAY DIFFRACTION;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; APOPTOSIS; BEHAVIOR, ANIMAL; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; DENDRITIC SPINES; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; ENDOCANNABINOIDS; ETHANOLAMINES; LUTEOLIN; MALE; MICE; NEUROGENESIS; PALMITIC ACIDS;

EID: 84889047743     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/18715273113129990084     Document Type: Article

References (59)

1. Nestler, E.J.; Barrot, M.; DiLeone, R.J.; Eisch, A.J.; Gold, S.J.; Monteggia, L.M. Neurobiology of depression. Neuron, 2002, 34(1), 13-25.
2. Rainer, Q.; Gardier, A.M.; Hen, R; David, D.J. Neurogenesis- dependent and independent effects of anti-depressant drugs. Med. Sci., 2009, 25(10), 795-798.
3. Bambico, F.R.; Duranti, A.; Tontini, A.; Tarzia, G.; Gobbi, G. Endocannabinoids in the treatment of mood disorders: evidence from animal models. Curr. Pharm. Des., 2009, 15(14) 1623-1646.
4. Degenhardt, B.F.; Darmani, N.A.; Johnson, J.C.; Towns, L.C.; Rhodes, D.C.; Trinh, C.; McClanahan, B.; DiMarzo, V. Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study. J. Am. Osteopat. Assoc., 2007, 107(9), 387-400.
5. Hill, M.N.; Gorzalka, B.B. The endocannabinoid system and the treatment of mood and anxiety disorders. CNS Neurol. Disord. Drug Targets, 2009, 8(6), 451-458.
6. Piomelli, D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci., 2003, 4(11), 873-884.
7. Hillard, C.J.; Jarrahian A. Cellular accumulation of anandamide: consensus and controversy. Br. J. Pharmacol., 2003, 140(5), 802-808.
8. Gobbi, G. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci.USA, 2005, 102(51),18620-18625.
9. Gorzalka, B.B.; Hill, M.N.; Hillard, C.J. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci. Biobehav. Rev., 2008, 32(6), 1152-1160.
10. Steiner, M.A.; Wotjak, C.T. Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. Prog. Brain Res., 2008, 170, 397-432.
11. de Kloet, E.R.; Joels, M.; Holsboer, F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci., 2005, 6(6), 463-475.
12. McEwen, B.S. Stress and hippocampal plasticity. Annu. Rev. Neurosci., 1999, 22, 105-122.
13. Ardayfio, P.; Kim, K.S. Anxiogenic-like effect of chronic corticosterone in the light-dark emergence task in mice. Behav. Neurosci., 2006, 120(2), 249-256.
14. Farley, S.; Apazoglou, K.; Witkin, J.M.; Giros, B.; Tzavara, E.T. Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. Int. J. Neuropsychopharmacol., 2010, 13(9), 1207-1218.
15. Papakostas G.I. Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder. J. Clin. Psychiatry, 2009, 70(5), 18-22.
16. David, D.J.; Samuels, B.A.; Rainer, Q.; Wang, J.W.; Marsteller, D.; Mendez, I.; Drew, M.; Craig, D.A.; Guiard, B.P.; Guilloux, J.P.; Artymyshyn, R.P.; Gardier, A.M.; Gerald, C.; Antonijevic, I.A.; Leonardo, E.D.; Hen, R. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron, 2009, 62(4), 479-493.
17. Lambert, D.M.; Vandevoorde, S.; Diependaele, G.; Govaerts, S.J.; Robert, A.R. Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice. Epilepsia, 2001, 42(3), 321-327.
18. Hoareau, L.; Ravanan, P.; Gonthier, M.P.; Delarue, P.; Goncalves, J.; Cesari, M.; Festy, F.; Roche, R. Effect of PEA on LPS inflammatory action in human adipocytes. Cytokine, 2006, 34(5-6), 291-296.
19. Ho, W.S.; Barrett, D.A.; Randall, M.D. 'Entourage' effects of N- palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Br. J. Pharmacol., 2008, 155(6), 837-846.
20. Sheerin, A.H.; Zhang, X.; Saucier, D.M.; Corcoran, M.E. Selective antiepileptic effects of N-palmitoylethanolamide, a putative endocannabinoid. Epilepsia, 2004, 45(10), 1184-1188.
21. Saito, V.M.; Wotjak, C.T.; Moreira, F.A. Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders? Rev. Bras. Psiquiatr., 32(1), S7-S14.
22. Yi, L.T.; Li, C.F.; Zhan, X.; Cui, C.C.; Xiao, F.; Zhou, L.P.; Xie, Y. Involvement of monoaminergic system in the antidepressant-like effect of the flavonoid naringenin in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2010, 34(7), 1223-1228.
23. Lin, L.Z.; Lu, S.; Harnly, J.M. Detection and quantification of glycosylated flavonoid malonates in celery, Chinese celery, and celery seed by LC-DAD-ESI/MS. J. Agric. Food Chem., 2007, 55(4), 1321-1326.
24. Fejes, S.; Kery, A.; Blazovics, A.; Lugasi, A.; Lemberkovics, E.; Petri, G.; Szoke, E. Investigation of the in vitro antioxidant effect of Petroselinum crispum (Mill.) Nym. ex A.W. Hill. Acta Pharm. Hung., 1998, 68(3), 150-156.
25. Materska, M.; Piacente, S.; Stochmal, A.; Pizza, C.; Oleszek, W.; Perucka, I. Isolation and structure elucidation of flavonoid and phenolic acid glycosides from pericarp of hot pepper fruit Capsicum annuum L. Phytochemistry, 2003, 63(8), 893-898.
26. Shimoi, K.; Masuda, S.; Furugori, M.; Esaki, S.; Kinae, N. Radioprotective effect of antioxidative flavonoids in gamma-ray irradiated mice. Carcinogenesis, 1994, 15(11), 2669-26672.
27. Lin, Y.; Shi, R.; Wang, X.; Shen, H.M. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr. Cancer Drug Targets, 2008, 8(7), 634-646.
28. Xu, B.; Li, X.X.; He, G.R.; Hu, J.J.; Mu, X.; Tian, S.; Du, G.H. Luteolin promotes long-term potentiation and improves cognitive functions in chronic cerebral hypoperfused rats. Eu. J. Pharmacol., 2010, 627(1-3), 99-105.
29. Coleta, M.; Campos, M.G.; Cotrim, M.D.; Lima, T.C.; Cunha, A.P. Assessment of luteolin (3',4',5,7-tetrahydroxyflavone) neuropharmacological activity. Behav. Brain Res., 2008, 189(1), 75-82.
30. Santarelli, L.; Saxe, M.; Gross, C.; Surget, A.; Battaglia, F.; Dulawa, S.; Weisstaub, N.; Lee, J.; Duman, R.; Arancio, O.; Belzung, C.; Hen, R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 2003, 301(5634), 805-809.
31. Porsolt, R.D. Animal model of depression. Biomedicine, 1979, 30(3), 139-140.
32. Malberg, J.E.; Eisch, A.J.; Nestler, E.J.; Duman, R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci., 2000, 20(24), 9104-9110.
33. Wallace, M.; Luine, V.; Arellanos, A.; Frankfurt, M. Ovariectomized rats show decreased recognition memory and spine density in the hippocampus and prefrontal cortex. Brain Res., 2006, 1126(1), 176-182.
34. Crupi, R.; Mazzon, E.; Marino, A.; La Spada, G.; Bramanti, P.; Cuzzocrea, S.; Spina, E. Melatonin treatment mimics the antidepressant action in chronic corticosterone-treated mice. J. Pineal Res., 2010, 49(2), 123-129.
35. Perera, T.D.; Coplan, J.D.; Lisanby, S.H.; Lipira, C.M.; Arif, M.; Carpio, C.; Spitzer, G.; Santarelli, L.; Scharf, B.; Hen, R.; Rosoklija, G.; Sackeim, H.A.; Dwork, A.J. Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J. Neurosci., 2007, 27(18), 4894-4901.
36. Antonijevic, I.A. Depressive disorders -is it time to endorse different pathophysiologies? Psychoneuroendocrinology, 2006, 31(1), 1-15.
37. Heuser, I.J.; Schweiger, U.; Gotthardt, U.; Schmider, J.; Lammers, C.H.; Dettling, M.; Yassouridis, A.; Holsboer, F. Pituitary-adrenal- system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am. J. Psychiatry, 1996, 153(1), 93-99.
38. Zhao, Y.; Ma, R.; Shen, J.; Su, H.; Xing, D.; Du, L. A mouse model of depression induced by repeated corticosterone injections. Eur. J. Pharmacol., 2008, 581(1-2), 113-120.
39. LoVerme, J.; La Rana, G.; Russo, R.; Calignano A, Piomelli D. The search for the palmitoylethanolamide receptor. Life Sci., 2005, 77(14), 1685-1698.
40. Lambert, D.M.; Vandevoorde, S.; Jonsson, K.O.; Fowler, C.J. The palmitoylethanolamide family: a new class of anti-inflammatory agents? Curr. Med. Chem., 2002, 9(6), 663-674.
41. Choi, A.Y.; Choi, J.H.; Lee, J.Y.; Yoon, K.S.; Choe, W.; Ha, J.; Yeo, E.J.; Kang, I. Apigenin protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis. Neurochem. Int., 2010, 57(2), 143-152.
42. Izuta, H.; Shimazawa, M.; Tazawa, S.; Araki, Y.; Mishima, S.; Hara H. Protective effects of Chinese propolis and its component, chrysin, against neuronal cell death via inhibition of mitochondrial apoptosis pathway in SH-SY5Y cells. J. Agric. Food Chem., 2008, 56(19), 8944-8953.
43. Yu HL, Deng X Q;. Li YJ.; Li YC.; Quan ZS.; Sun XYN- palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice. Pharmacol. Rep., 2011, 63(3), 834-839.
44. Zomkowski, A.D.; Santos, A.R.; Rodrigues AL. Putrescine produces antidepressant-like effects in the forced swimming test and in the tail suspension test in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2006, 30(8), 1419-1425.
45. Porsolt, R.D.; Bertin, A.; Jalfre, M. Behavioral despair in mice: a primary screening test for antidepressants. Arc. Int. Pharmacodyn. Ther., 1977, 229(2), 327-336.
46. Steru, L.; Chermat, R.; Thierry, B.; Simon, P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology, 1985, 85(3), 367-370.
47. Carbajal, D.; Ravelo, Y.; Molina, V.; Mas, R.; Arruzazabala Mde, L. D- 004, a lipid extract from royal palm fruit, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice. Pharmacol. Biochem. Behav., 2009, 92(3), 465-468.
48. Galdino, P.M.; Nascimento, M.V.; Sampaio, B.L.; Ferreira, R.N.; Paula, J.R.; Costa, E.A. Antidepressant-like effect of Lafoensia pacari A. St.-Hil. ethanolic extract and fractions in mice. J. Ethnopharmacol., 2009, 124(3), 581-585.
49. Pariante, C.M.; Pearce, B.D.; Pisell, T.L.; Owens, M.J.; Miller, A.H. Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Mol. Pharmacol., 1997, 52(4), 571-581.
50. Numakawa T.; Yokomaku D.; Richards M.; Hori H.; Adachi N.; Kunugi H. Functional interactions between steroid hormones and neurotrophin BDNF. World J. Biol. Chem., 2010, 1(5), 133-143.
51. Thompson, R.J.; Berenbaum, H.; Bredemeier, K. Cross-sectional and longitudinal relations between affective instability and depression. J. Affect. Disorders, 2011, 130(1-2), 53-59.
52. Kutiyanawalla, A.; Terry, A.V., Jr.; Pillai, A. Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatment. PloS One, 2010, 6(10), e26153.
53. Gourley, S.L.; Kiraly, D.D.; Howell, J.L.; Olausson, P.; Taylor, J.R. Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone. Biol. Psychiatry, 2008, 64(10), 884-890.
54. Anacker, C.; Zunszain, P.A.; Carvalho, L.A.; Pariante, C.M. The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology, 2011, 36(3), 415-425.
55. Saarelainen, T.; Hendolin, P.; Lucas, G.; Koponen, E.; Sairanen, M.; MacDonald, E.; Agerman, K.; Haapasalo, A.; Nawa, H.; Aloyz, R.; Ernfors, P.; Castren, E. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant- induced behavioral effects. J. Neurosci., 2003, 23(1), 349-357.
56. Bachis, A.; Cruz, M.I.; Nosheny, R.L.; Mocchetti, I. Chronic unpredictable stress promotes neuronal apoptosis in the cerebral cortex. Neurosci. Lett., 2008, 442(2), 104-108.
57. Salvesen, G.S. Caspases and apoptosis. Essays Biochem., 2002, 38, 9-19.
58. Kowaltowski, A.J.; Fenton, R.G.; Fiskum, G. Bcl-2 family proteins regulate mitochondrial reactive oxygen production and protect against oxidative stress. Free Radic. Biol. Med., 2004, 37, 1845-1853.
59. Finucane, D.M.; Bossy-Wetzel, E.; Waterhouse, N.J.; Cotter, T.G.; Green, D.R. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J. Biol. Chem., 1999, 274(4), 2225-2233.